“…It is important to highlight specific aspects of our ERAS protocol that may differ from those protocols discussed in Gynecologic Oncology literature thus far. Specifically, while use of TAP blocks have shown a reduction in immediate intra- and post-operative opioid use in open abdominal surgeries ( Bhattacharjee et al, 2014 , McDonnell et al, 2007 , Carney et al, 2010 , Peltrini et al, 2020 ), administration of TAP blocks remains controversial in Gynecologic Oncology ( Nelson et al, 2019 , Bisch et al, 2019 , Chang et al, 2018 ). To the best of our knowledge, most large retrospective studies of ERAS in Gynecologic Oncology have incorporated use of epidurals, incisional liposomal bupivacaine or sacral nerve blocks for multimodal pain control regimens ( Nelson et al, 2019 , Boitano et al, 2018 , Kalogera et al, 2013 , Kalogera et al, 2016 , Bergstorm et al, 2018 , Wijk et al, 2014 , Modesitt et al, 2016 , Wijk et al, 2019 , Bisch et al, 2018 ).…”